KROS
Keros Therapeutics Inc
11.60$
+3.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | – | 100.0% | – | 100.0% | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 194.7% | 179.9% | 154.2% | 165.2% | 341.1% | 290.6% | 335.8% | – | – | 9,983.0% | – | 1.5% | – | 514.0% | – | – | – | – | 6,887.5% | 172.7% | 333.7% | 827.0% | 80.9% | 10.9% | 0.2% | 2.0% | 2.8% | 103.9% | 109.8% | – | – | |
| -94.7% | -79.9% | -54.2% | -65.2% | -241.1% | -190.6% | -235.8% | – | – | -9,883.0% | – | 98.5% | – | -414.0% | – | – | – | – | -6,787.5% | 100.0% | 100.0% | 100.0% | 19.1% | 89.1% | 100.0% | 98.0% | 97.2% | 100.0% | -9.8% | – | – | |
| 194.7% | 179.9% | 154.2% | 166.4% | 341.1% | 290.6% | 335.8% | – | – | 9,983.0% | – | 94.2% | – | 23,281.0% | – | – | – | – | 426,750.0% | 26,218.9% | 46,094.0% | 109,500.0% | 12,686.9% | 1,500.0% | 23.1% | 239.4% | 136.9% | 4,652.5% | 4,386.1% | 122.9% | 228.6% | |
| 19.6% | 26.2% | 38.9% | 42.7% | 79.1% | 146.0% | 142.1% | – | – | 5,658.0% | – | 30.2% | – | 7,447.0% | – | – | – | – | 114,350.0% | 6,367.1% | 12,419.3% | 26,921.6% | 2,530.9% | 350.6% | 5.0% | 79.7% | 71.0% | 3,050.1% | 2,764.9% | 47.4% | 122.4% | |
| 214.3% | 206.0% | 193.0% | 209.1% | 420.2% | 436.6% | 477.9% | – | – | 5,658.0% | – | 122.8% | – | 30,728.0% | – | – | – | – | 534,212.5% | 32,586.0% | 58,513.3% | 136,421.6% | 15,136.9% | 1,839.7% | 28.0% | 317.1% | 205.1% | 7,702.6% | 7,041.1% | 170.3% | 348.6% | |
| -114.3% | -106.0% | -93.0% | -109.1% | -420.2% | -436.6% | -477.9% | – | – | -15,541.0% | – | -24.3% | – | -30,728.0% | – | – | – | – | -541,000.0% | -32,486.0% | -58,413.3% | -136,321.6% | -15,117.8% | -1,750.6% | 72.0% | -219.2% | -107.9% | -7,602.6% | -7,051.0% | -170.3% | -305.8% | |
| 0.1% | 0.1% | 0.1% | 0.0% | 0.1% | 0.0% | 0.1% | – | – | 1.0% | – | 0.0% | – | 3,462.0% | – | – | – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | |
| -127.3% | -114.1% | -142.0% | -110.0% | -482.6% | -430.3% | -481.4% | – | – | -15,622.0% | – | -24.7% | – | -27,266.0% | – | – | – | – | -493,000.0% | -28,142.0% | -51,944.6% | -122,316.2% | -13,648.5% | -1,503.2% | 75.0% | -181.2% | -61.0% | -6,487.0% | -6,459.9% | -158.0% | -259.5% | |
| 0.1% | 0.1% | -48.7% | 92.1% | -6.9% | 0.0% | -6.2% | – | – | -79.0% | – | 10.0% | – | -3,462.0% | – | – | – | – | -2,625.0% | 2,665.7% | -333.7% | – | – | 9.9% | 4.8% | -12.2% | -10.0% | -393.2% | – | 12.2% | – | |
| -127.3% | -114.1% | -142.0% | -110.0% | -475.7% | -430.3% | -481.4% | – | – | -15,622.0% | – | -34.7% | – | -27,266.0% | – | – | – | – | -493,000.0% | -28,142.0% | -51,944.6% | -122,316.2% | -13,648.5% | -1,513.0% | 70.3% | -169.0% | -51.0% | -6,093.8% | -6,459.9% | -158.0% | -250.6% | |
| -105.3% | -89.0% | -139.6% | -14.7% | -480.0% | -427.5% | -478.5% | – | – | -15,428.0% | – | -23.2% | – | -26,958.0% | – | – | – | – | -486,112.5% | -27,969.2% | -51,610.8% | -121,489.2% | -13,567.5% | -958.0% | 75.2% | -179.2% | -58.3% | -6,383.1% | -6,350.1% | -155.8% | -254.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.